Form 4: CONMED Corp Executive Todd W. Garner Reports Stock Option Grant

Executive Vice President & CFO of CONMED Corp, Todd W. Garner, reports the acquisition of 61,475 stock options.

Summary

• Todd W. Garner, Executive Vice President & CFO of CONMED Corp, filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on March 3, 2025.
• Garner acquired 61,475 options to purchase common stock at an exercise price of $58.33.
• These options were granted under the company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five-year period.
• Following the reported transaction, Garner directly owns 61,475 derivative securities.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard reporting of executive compensation.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
• The grant incentivizes the executive to improve company performance, which could benefit all stakeholders.

Key Dates